<html xmlns="http://www.w3.org/1999/xhtml"><body><table class="table"><caption /><tr><th class="cell">HRQOL composite/subscore </th><th class="cell">DMD used </th><th class="cell">n5 </th><th class="cell">Mean HRQOL </th><th class="cell">SD </th><th class="cell">P </th><th class="cell">Pairwise comparisons* </th></tr><tr><td class="cell">Physical health composite</td><td class="cell">1. Natalizumab only</td><td class="cell">107</td><td class="cell">54.9</td><td class="cell">20.9</td><td class="cell">0.002</td><td class="cell">3 vs 1, P50.001</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">71</td><td class="cell">55.8</td><td class="cell">20.5</td><td class="empty"></td><td class="cell">3 vs 2, P50.012</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">408</td><td class="cell">62.8</td><td class="cell">20.8</td><td class="empty"></td><td class="cell">3 vs 4, P50.014</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">351</td><td class="cell">59.0</td><td class="cell">20.7</td><td class="empty"></td><td class="cell">3 vs 5, P50.003</td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">919</td><td class="cell">59.0</td><td class="cell">22.1</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Mental health composite</td><td class="cell">1. Natalizumab only</td><td class="cell">118</td><td class="cell">64.5</td><td class="cell">21.4</td><td class="cell">0.012</td><td class="cell">5 vs 2, P50.027</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">85</td><td class="cell">62.9</td><td class="cell">20.6</td><td class="empty"></td><td class="cell">5 vs 4, P50.007</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">450</td><td class="cell">67.8</td><td class="cell">21.7</td><td class="empty"></td><td class="cell">3 vs 4, P50.045</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">384</td><td class="cell">64.8</td><td class="cell">21.7</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1078</td><td class="cell">68.2</td><td class="cell">21.0</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Physical health subscore</td><td class="cell">1.Natalizumab only</td><td class="cell">122</td><td class="cell">56.6</td><td class="cell">32.7</td><td class="cell">v0.001</td><td class="cell">3 vs 1, Pv0.001</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">86</td><td class="cell">55.8</td><td class="cell">33.6</td><td class="empty"></td><td class="cell">3 vs 2, P50.001</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">463</td><td class="cell">68.6</td><td class="cell">30.0</td><td class="empty"></td><td class="cell">3 vs 4, P50.013</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">401</td><td class="cell">63.1</td><td class="cell">30.5</td><td class="empty"></td><td class="cell">3 vs 5, Pv0.001</td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1125</td><td class="cell">56.4</td><td class="cell">34.9</td><td class="empty"></td><td class="cell">4 vs 5, Pv0.001</td></tr><tr><td class="cell">Role limitations physical subscore</td><td class="cell">1. Natalizumab only</td><td class="cell">119</td><td class="cell">43.1</td><td class="cell">43.8</td><td class="cell">0.023</td><td class="cell">3 vs 1, P50.044</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">86</td><td class="cell">44.2</td><td class="cell">42.1</td><td class="empty"></td><td class="cell">3 vs 4, P50.034</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">463</td><td class="cell">52.0</td><td class="cell">43.8</td><td class="empty"></td><td class="cell">3 vs 5, P50.001</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">400</td><td class="cell">45.8</td><td class="cell">43.1</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1123</td><td class="cell">44.3</td><td class="cell">43.3</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Pain subscore</td><td class="cell">1. Natalizumab only</td><td class="cell">121</td><td class="cell">70.4</td><td class="cell">27.9</td><td class="cell">0.003</td><td class="cell">3 vs 2, P50.001</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">85</td><td class="cell">65.6</td><td class="cell">27.4</td><td class="empty"></td><td class="cell">3 vs 4, P50.003</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">463</td><td class="cell">75.5</td><td class="cell">24.8</td><td class="empty"></td><td class="cell">3 vs 5, P50.017</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">397</td><td class="cell">70.1</td><td class="cell">26.2</td><td class="empty"></td><td class="cell">2 vs 5, P50.029</td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1129</td><td class="cell">72.0</td><td class="cell">26.2</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Emotional wellbeing subscore</td><td class="cell">1. Natalizumab only</td><td class="cell">122</td><td class="cell">67.1</td><td class="cell">19.4</td><td class="cell">0.006</td><td class="cell">4 vs 5, Pv0.001</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">86</td><td class="cell">67.6</td><td class="cell">18.7</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">464</td><td class="cell">68.6</td><td class="cell">19.0</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">402</td><td class="cell">66.3</td><td class="cell">19.0</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1132</td><td class="cell">70.1</td><td class="cell">18.2</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Health perception subscore</td><td class="cell">1. Natalizumab only</td><td class="cell">122</td><td class="cell">54.8</td><td class="cell">23.5</td><td class="cell">0.017</td><td class="cell">3 vs 2, P50.005</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">86</td><td class="cell">50.3</td><td class="cell">19.3</td><td class="empty"></td><td class="cell">3 vs 4, P50.047</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">464</td><td class="cell">57.8</td><td class="cell">22.3</td><td class="empty"></td><td class="cell">5 vs 2, P50.007</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">401</td><td class="cell">54.7</td><td class="cell">21.4</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1130</td><td class="cell">57.2</td><td class="cell">23.4</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Social function subscore</td><td class="cell">1. Natalizumab only</td><td class="cell">117</td><td class="cell">66.7</td><td class="cell">22.8</td><td class="cell">0.005</td><td class="cell">3 vs 1, P50.006</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">83</td><td class="cell">68.1</td><td class="cell">22.6</td><td class="empty"></td><td class="cell">3 vs 4, P50.008</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">455</td><td class="cell">73.6</td><td class="cell">22.6</td><td class="empty"></td><td class="cell">3 vs 5, P50.001</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">388</td><td class="cell">69.1</td><td class="cell">24.0</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1094</td><td class="cell">69.0</td><td class="cell">24.9</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Cognitive function subscore</td><td class="cell">1.Natalizumab only</td><td class="cell">122</td><td class="cell">63.4</td><td class="cell">27.9</td><td class="cell">0.008</td><td class="cell">5 vs 2, P50.004</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">86</td><td class="cell">59.5</td><td class="cell">29.1</td><td class="empty"></td><td class="cell">5 vs 4, P50.038</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">464</td><td class="cell">65.5</td><td class="cell">27.2</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">402</td><td class="cell">65.0</td><td class="cell">27.2</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1132</td><td class="cell">68.2</td><td class="cell">26.3</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Health distress subscore</td><td class="cell">1.Natalizumab only</td><td class="cell">122</td><td class="cell">56.8</td><td class="cell">28.0</td><td class="cell">0.033</td><td class="cell">4 vs 5, P50.027</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">86</td><td class="cell">55.6</td><td class="cell">27.5</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">464</td><td class="cell">61.0</td><td class="cell">27.6</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">402</td><td class="cell">58.3</td><td class="cell">26.8</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">1130</td><td class="cell">61.8</td><td class="cell">27.0</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="cell">Sexual function subscore</td><td class="cell">1. Natalizumab only</td><td class="cell">113</td><td class="cell">64.2</td><td class="cell">31.5</td><td class="cell">0.033</td><td class="cell">3 vs 2, P50.035</td></tr><tr><td class="empty"></td><td class="cell">2. Fingolimod only</td><td class="cell">74</td><td class="cell">62.4</td><td class="cell">29.2</td><td class="empty"></td><td class="cell">3 vs 4, P50.039</td></tr><tr><td class="empty"></td><td class="cell">3. Glatiramer only</td><td class="cell">422</td><td class="cell">70.5</td><td class="cell">29.4</td><td class="empty"></td><td class="cell">3 vs 5, P50.004</td></tr><tr><td class="empty"></td><td class="cell">4. Interferons only</td><td class="cell">369</td><td class="cell">66.0</td><td class="cell">30.2</td><td class="empty"></td><td class="empty"></td></tr><tr><td class="empty"></td><td class="cell">5. No DMD</td><td class="cell">976</td><td class="cell">65.4</td><td class="cell">31.3</td><td class="empty"></td><td class="empty"></td></tr></table></body></html>